Transcatheter aortic valve implantation with the 34 mm self-expanding CoreValve Evolut R: initial experience in 101 patients from a multicenter registry.
CONCLUSIONS: Initial experience with the new self-expanding CoreValve Evolut R® 34 mm valve is characterized by high procedural success, excellent hemodynamic performance and a low early complication rate.
PMID: 29808820 [PubMed - as supplied by publisher]
Source: EuroIntervention - Category: Cardiovascular & Thoracic Surgery Tags: EuroIntervention Source Type: research
More News: Bleeding | Cardiology | Cardiovascular & Thoracic Surgery | Heart | Heart Valve Disease | Heart Valves | Stroke